Lymphoma

Trial Tidal Study
Cancer Type Haematological Cancers and Lymphoma
Hospital(s) Belfast City Hospital
Information

A Multicenter, Open-label, single-arm, Phase 2 Study of Zandelisib (ME401) in Subjects with Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Systemic Therapies